163 related articles for article (PubMed ID: 8764936)
1. Expression of CD44 isoforms in human renal cell carcinomas.
Heider KH; Ratschek M; Zatloukal K; Adolf GR
Virchows Arch; 1996 Jul; 428(4-5):267-73. PubMed ID: 8764936
[TBL] [Abstract][Full Text] [Related]
2. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
5. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
6. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
8. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteopontin and CD44 molecule in papillary renal cell tumors.
Matusan K; Dordevic G; Mozetic V; Lucin K
Pathol Oncol Res; 2005; 11(2):108-13. PubMed ID: 15999156
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
12. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
13. CD44 expression in soft tissue sarcomas.
Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H
Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
Imam H; Eriksson B; Oberg K
Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
[TBL] [Abstract][Full Text] [Related]
15. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
[TBL] [Abstract][Full Text] [Related]
18. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CD44 and isoforms v4, v5, v6, v7, v10--new prognostic parameters in ductal pancreatic carcinoma?].
Böttger T; Maschek H; Gottwald W; Lobo M; Brenner W; Junginger T
Chirurg; 1998 Oct; 69(10):1089-92. PubMed ID: 9833191
[TBL] [Abstract][Full Text] [Related]
20. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
